Empagliflozin (JARDIANCE): Revolutionizing Type 2 Diabetes Management | Expert Insights скачать в хорошем качестве

Empagliflozin (JARDIANCE): Revolutionizing Type 2 Diabetes Management | Expert Insights

Struggling with Type 2 Diabetes? Discover how **Empagliflozin (JARDIANCE)**, an SGLT2 inhibitor, can transform your diabetes management while protecting your heart and kidneys! In this video, **Dr. Hosam Khalaf**, a Certified Clinical Pharmacist, dives deep into the science, benefits, and practical use of JARDIANCE for Type 2 Diabetes. ✅ *Key Topics Covered:* **How JARDIANCE Works**: Blocks SGLT2 proteins in the kidneys to flush excess glucose via urine, lowering blood sugar *without insulin*. **Beyond Glucose Control**: Reduces cardiovascular death risk by 38% and slows kidney disease progression by 28% in high-risk patients. **Optimal Dosing**: 10 mg or 25 mg once daily (morning), with adjustments for kidney function (eGFR ≥45 mL/min). **Safety First**: Critical warnings for ketoacidosis, genital infections, and rare but serious Fournier’s gangrene. **Real-World Benefits**: Weight loss (2-3% body weight), blood pressure reduction, and synergy with metformin or GLP-1 agonists. *🔔 Subscribe to ZA PHARMACY* for evidence-based diabetes insights! Hit the bell to stay updated on medication guides, expert Q&As, and cutting-edge research from Dr. Khalaf. *💬 Engage With Us:* Have you tried JARDIANCE? Share your experience below or ask Dr. Khalaf your questions! --- #Type2Diabetes #Jardiance #Empagliflozin #DiabetesManagement #BloodSugarControl #HeartHealth #KidneyProtection #SGLT2Inhibitors #DiabetesAwareness #PharmacyAdvice #ClinicalPharmacist #ZaPharmacy --- *Disclaimer:* This video is for educational purposes only. JARDIANCE requires a prescription and is not for Type 1 Diabetes. Consult your healthcare provider before use. Side effects like ketoacidosis or infections require immediate medical attention. Individual results may vary. “Jardiance for Type 2 Diabetes,” “SGLT2 inhibitor benefits,” “empagliflozin side effects,” “cardiovascular protection in diabetes,” “Jardiance dosage guide,” “diabetes and kidney disease,” “A1c reduction strategies.” *Sources Cited:* StatPearls/NIH FDA Approvals & Clinical Trials WebMD European Medicines Agency --- *Optimized for Engagement:* Highlights urgent benefits (heart/kidney protection) to address patient priorities. Blends clinical data (EMPA-REG trial) with practical advice (cost-saving tips). Encourages interaction through patient stories and monthly Q&A responses. JARDIANCE reduces hospitalization for heart failure by 23% in post-heart attack patients, though recent trials like EMPACT-MI show mixed results. Emerging studies explore its role in non-diabetic CKD and metabolic syndrome. *Alert:* Higher hypoglycemia risk in pediatric patients (10+ years). --- Empower your diabetes journey with science-backed solutions! 🌟